


The global automatic plate washer market is valued at US$179.4 million in 2025 and is forecast to reach US$247.2 million by 2031, a compound annual growth rate (CAGR) of 5.5% over 2025-2031. The report covers standalone, programmable laboratory instruments that dispense and aspirate wash solution in microplates between assay steps: strip washers, 96-well and 384-well capable units, deep-well washers and magnetic-bead and cell-wash capable systems sold new to end-user laboratories. Manual and semi-automatic manifolds, consumables, spare parts, service contracts, plate readers, liquid handlers and integrated ELISA processors where the washer is not priced separately are excluded.
The report segments the market by type and application across five regions and 27 country-level lines. General-purpose plate washers account for 67.0% of 2025 value (US$120.3 million, 4.4% CAGR) and special-purpose plate washers for 33.0% (US$59.1 million, 7.5% CAGR). Biopharma and Biotech is the largest application at 36.5% of 2025 value (6.4% CAGR), followed by Hospitals and Clinical Labs at 29.4% (5.5% CAGR); CROs and CDMOs is the fastest growing at 6.7% CAGR. North America holds 32.3% of 2025 value, Asia Pacific 30.4% and is the fastest growing region at 6.9% CAGR. Values are Navadhi Market Research estimates built from observed list prices, tender prices and installed-base anchors; no company discloses plate washer revenue.
Scope of the Global Automatic Plate Washer Market Strategic Research Report
This report covers market value (US$ million) for 2022-2031, with 2025 as the base year and 2026-2031 as the forecast period. It analyses two instrument types, four applications, five regions and 27 country-level lines, and includes profiles of 17 companies, competitive landscape, Porter's Five Forces, PESTLE, SWOT and future trends. Unit volumes are discussed as an installed-base analysis (Section 2.4) and are not published as a series.
Segment by Type
Segment by Application
Who Can Use This Report?
1. Executive Summary
1.1 Market Definition and Scope
1.2 Market Size and Growth Trajectory
1.3 Principal Growth Drivers
1.4 Segment and Regional Highlights
1.5 Competitive Structure and Key Corporate Developments
1.6 Principal Risks
1.7 Closing Outlook
2. Industry Overview & Forecast
2.1 Market Definition and Scope
2.2 Market Size and Historical Performance
2.3 Forecast and Growth Logic
2.4 Volume and Installed-Base Analysis
2.5 Value Chain and Pricing Dynamics
3. Market Segmentation by Type
3.1 Overview of the Type Dimension
3.1.1 General-purpose Plate Washers
3.1.2 Special-purpose Plate Washers
3.1.3 Comparative Mix Shift and Structural Implications
4. Market Segmentation by Application
4.1 Overview of Application Structure
4.1.1 Hospitals and Clinical Labs
4.1.1.1 Segment Characteristics and Market Scale
4.1.1.2 Instrument Profile and Procurement Patterns
4.1.1.3 Buyer Behaviour, Replacement Cycles, and Risks
4.1.2 Biopharma and Biotech
4.1.2.1 Segment Characteristics and Market Scale
4.1.2.2 Instrument Profile and Procurement Patterns
4.1.2.3 Buyer Behaviour, Replacement Cycles, and Risks
4.1.3 CROs and CDMOs
4.1.3.1 Segment Characteristics and Market Scale
4.1.3.2 Instrument Profile and Procurement Patterns
4.1.3.3 Buyer Behaviour, Replacement Cycles, and Risks
4.1.4 Others
4.1.4.1 Segment Characteristics and Market Scale
4.1.4.2 Instrument Profile and Procurement Patterns
4.1.4.3 Buyer Behaviour, Replacement Cycles, and Risks
4.2 Comparative Segment Analysis
5. Regional Market Forecast
5.1 North America
5.1.1 Regional Overview
5.1.2 Key Growth Drivers
5.1.3 Regulatory & Infrastructure Landscape
5.1.4 Country-Level Analysis
5.1.5 Market Forecast 2025–2031
5.2 Europe
5.2.1 Regional Overview
5.2.2 Key Growth Drivers
5.2.3 Regulatory & Infrastructure Landscape
5.2.4 Country-Level Analysis
5.2.5 Market Forecast 2025–2031
5.3 Asia Pacific
5.3.1 Regional Overview
5.3.2 Key Growth Drivers
5.3.3 Regulatory & Infrastructure Landscape
5.3.4 Country-Level Analysis
5.3.5 Market Forecast 2025–2031
5.4 Latin America
5.4.1 Regional Overview
5.4.2 Key Growth Drivers
5.4.3 Regulatory & Infrastructure Landscape
5.4.4 Country-Level Analysis
5.4.5 Market Forecast 2025–2031
5.5 Middle East and Africa
5.5.1 Regional Overview
5.5.2 Key Growth Drivers
5.5.3 Regulatory & Infrastructure Landscape
5.5.4 Country-Level Analysis
5.5.5 Market Forecast 2025–2031
6. Country-Level Market Forecast
6.1 North America
6.1.1 United States
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.2.1 Germany
6.2.2 United Kingdom
6.2.3 France
6.2.4 Italy
6.2.5 Spain
6.2.6 Rest of Europe
6.3 Asia Pacific
6.3.1 China
6.3.2 Japan
6.3.3 India
6.3.4 South Korea
6.3.5 Australia
6.3.6 Southeast Asia
6.3.7 Rest of Asia Pacific
6.4 Latin America
6.4.1 Brazil
6.4.2 Argentina
6.4.3 Colombia
6.4.4 Chile
6.4.5 Rest of Latin America
6.5 Middle East and Africa
6.5.1 GCC Countries
6.5.2 Turkey
6.5.3 Israel
6.5.4 South Africa
6.5.5 Egypt
6.5.6 Rest of Middle East and Africa
7. Growth Drivers & Inhibitors
7.1 Strategic Context
7.2 Market Growth Drivers
7.2.1 Entrenchment of Plate-Based Immunoassay and ELISA Workflows in Clinical Diagnostics
7.2.2 Accelerating Biopharma Bioanalysis, CRO, and CDMO Testing Requirements
7.2.3 Demand for Automated Washing to Reduce Assay Variability and Manual Labour
7.2.4 Expansion of Laboratory Capacity in Asia Pacific and Other Emerging Markets
7.2.5 Persistent Replacement Cycle Demand from an Established Installed Base
7.2.6 Growing Demand for Workflow Consistency Across Multi-Site Laboratory Networks
7.3 Market Restraints
7.3.1 Price Pressure from Low-Cost Asian Instrument Manufacturers in the General-Purpose Segment
7.3.2 Integration of Washers into Fully Automated ELISA and Immunoassay Systems
7.3.3 Extended Instrument Lifecycle Constraining Replacement Velocity
7.3.4 Constrained Academic and Biotech Funding in Cyclical Years
7.3.5 Absence of Transparent Market Data Limiting Strategic Pricing and Investment
7.4 Impact Assessment Summary
7.5 Integrated Assessment
8. Key Company Profiles
8.1 Thermo Fisher Scientific
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2025–2031)
8.2 Agilent Technologies
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2025–2031)
8.3 Bio-Rad Laboratories
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2025–2031)
8.4 Tecan
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2025–2031)
8.5 Biobase
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2025–2031)
8.6 Molecular Devices
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2025–2031)
8.7 Berthold Technologies
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2025–2031)
8.8 Dynex Technologies
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2025–2031)
8.9 CYTENA
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2025–2031)
8.10 Awareness Technology
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2025–2031)
8.11 CAPP (AHN Biotechnologie)
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2025–2031)
8.12 Biosan
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2025–2031)
8.13 Mindray
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2025–2031)
8.14 Autobio
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2025–2031)
8.15 KHB
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2025–2031)
8.16 URIT
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2025–2031)
8.17 Rayto
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2025–2031)
9. Competitive Landscape
9.1 Competitive Landscape Overview
9.1.1 Profiled Company Reference Table
9.1.2 Why Market Share Cannot Be Measured
9.1.3 Competitive Intensity and Strategic Differentiation
9.2 Competitive Intensity Assessment
9.2.1 Structural Grouping of Participants
9.2.2 Capacity Versus Demand Dynamics
9.2.3 Pricing Environment
9.2.4 Barriers to Entry and Exit
9.3 Key Player Strategies & Positioning
9.3.1 Strategic Group Map
9.3.2 Platform Integrators: Scale as a Differentiator
9.3.3 Specialist Automation: Tecan's Niche Depth
9.3.4 Chinese IVD Platforms: Volume, Price, and Domestic Scale
9.3.5 Low-Cost Volume Suppliers: Biobase and Rayto
9.3.6 Emerging and Niche Entrants
9.3.7 R&D and Technology Investment Trends
9.3.8 M&A and Partnership Activity (2022–Present)
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Incumbent Landscape Without Disclosed Market Shares
9.4.2 Emerging Competitive Threats
9.4.3 Consolidation vs. Fragmentation Outlook
9.4.4 Competitive Response Matrix
9.4.5 Strategic Recommendations for 2026–2031
10. Porter's Five Forces Analysis
10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry
11. PESTLE Analysis
11.1 Overview
11.2 Political
11.3 Economic
11.4 Social
11.5 Technological
11.6 Legal and Regulatory
11.7 Environmental
11.8 PESTLE Summary Table
12. SWOT Analysis
12.1.1 Detailed Analysis
12.1.1.1 Strengths
12.1.1.2 Weaknesses
12.1.1.3 Opportunities
12.1.1.4 Threats
12.1.2 Strategic Implications and Priority Actions
13. Future Trends & Outlook
13.1 Overview
13.2 Accelerating Shift Toward Special-Purpose Plate Washers
13.3 Asia Pacific's Rising Share and the Centre of Gravity Shift
13.4 Persistent Price Duality and the Commoditisation of General-Purpose Instruments
13.5 CRO and CDMO Sector Expansion as a Structural Demand Driver
13.6 Hospital and Clinical Lab Modernisation as a Volume Driver in Emerging Markets
13.7 Product Innovation in Multifunction and High-Density Plate Formats
13.8 Scenario Divergence and the Risk of Downside Growth Compression
13.9 Summary of Future Trends
13.10 Forward Outlook
List of Exhibits
Exhibit 2.1: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.2: Forecast of Global Market (in USD Mn)
Exhibit 2.3: Forecast of North America (in USD Mn)
Exhibit 2.4: Forecast of Europe (in USD Mn)
Exhibit 2.5: Forecast of Asia Pacific (in USD Mn)
Exhibit 2.6: Forecast of Latin America (in USD Mn)
Exhibit 2.7: Forecast of Middle East and Africa (in USD Mn)
Exhibit 3.8: Forecast of General-purpose Plate Washers (in USD Mn)
Exhibit 3.9: Forecast of Special-purpose Plate Washers (in USD Mn)
Exhibit 4.10: Forecast of Hospitals and Clinical Labs (in USD Mn)
Exhibit 4.11: Forecast of Biopharma and Biotech (in USD Mn)
Exhibit 4.12: Forecast of CROs and CDMOs (in USD Mn)
Exhibit 4.13: Forecast of Others (in USD Mn)
Exhibit 6.14: Forecast of North America (in USD Mn)
Exhibit 6.15: Forecast of United States (in USD Mn)
Exhibit 6.16: Forecast of Canada (in USD Mn)
Exhibit 6.17: Forecast of Mexico (in USD Mn)
Exhibit 6.18: Forecast of Europe (in USD Mn)
Exhibit 6.19: Forecast of Germany (in USD Mn)
Exhibit 6.20: Forecast of United Kingdom (in USD Mn)
Exhibit 6.21: Forecast of France (in USD Mn)
Exhibit 6.22: Forecast of Italy (in USD Mn)
Exhibit 6.23: Forecast of Spain (in USD Mn)
Exhibit 6.24: Forecast of Rest of Europe (in USD Mn)
Exhibit 6.25: Forecast of Asia Pacific (in USD Mn)
Exhibit 6.26: Forecast of China (in USD Mn)
Exhibit 6.27: Forecast of Japan (in USD Mn)
Exhibit 6.28: Forecast of India (in USD Mn)
Exhibit 6.29: Forecast of South Korea (in USD Mn)
Exhibit 6.30: Forecast of Australia (in USD Mn)
Exhibit 6.31: Forecast of Southeast Asia (in USD Mn)
Exhibit 6.32: Forecast of Rest of Asia Pacific (in USD Mn)
Exhibit 6.33: Forecast of Latin America (in USD Mn)
Exhibit 6.34: Forecast of Brazil (in USD Mn)
Exhibit 6.35: Forecast of Argentina (in USD Mn)
Exhibit 6.36: Forecast of Colombia (in USD Mn)
Exhibit 6.37: Forecast of Chile (in USD Mn)
Exhibit 6.38: Forecast of Rest of Latin America (in USD Mn)
Exhibit 6.39: Forecast of Middle East and Africa (in USD Mn)
Exhibit 6.40: Forecast of GCC Countries (in USD Mn)
Exhibit 6.41: Forecast of Turkey (in USD Mn)
Exhibit 6.42: Forecast of Israel (in USD Mn)
Exhibit 6.43: Forecast of South Africa (in USD Mn)
Exhibit 6.44: Forecast of Egypt (in USD Mn)
Exhibit 6.45: Forecast of Rest of Middle East and Africa (in USD Mn)
*If Applicable.